Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 607,141
  • Shares Outstanding, K 191,527
  • Annual Sales, $ 6,170 K
  • Annual Income, $ -69,920 K
  • EBIT $ -83 M
  • EBITDA $ -81 M
  • 60-Month Beta 1.20
  • Price/Sales 101.80
  • Price/Cash Flow N/A
  • Price/Book 7.93

Options Overview Details

View History
  • Implied Volatility 199.30% ( +127.33%)
  • Historical Volatility 33.72%
  • IV Percentile 96%
  • IV Rank 42.02%
  • IV High 443.77% on 08/05/24
  • IV Low 22.10% on 10/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 158
  • Volume Avg (30-Day) 176
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 22,571
  • Open Int (30-Day) 26,604

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +81.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.04 +4.28%
on 06/30/25
3.65 -13.15%
on 06/16/25
-0.33 (-9.43%)
since 06/11/25
3-Month
2.94 +7.82%
on 05/15/25
3.72 -14.90%
on 05/02/25
+0.03 (+0.96%)
since 04/11/25
52-Week
2.70 +17.41%
on 04/09/25
4.72 -32.91%
on 09/09/24
-0.34 (-9.69%)
since 07/11/24

Most Recent Stories

More News
Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus

ABUS : 3.17 (-3.35%)
Arbutus: Q1 Earnings Snapshot

Arbutus: Q1 Earnings Snapshot

ABUS : 3.17 (-3.35%)
Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update

ABUS : 3.17 (-3.35%)
Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025

ABUS : 3.17 (-3.35%)
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025

ABUS : 3.17 (-3.35%)
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

ABUS : 3.17 (-3.35%)
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna

ABUS : 3.17 (-3.35%)
Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO

ABUS : 3.17 (-3.35%)
Arbutus Provides 2025 Corporate and Financial Update

ABUS : 3.17 (-3.35%)
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat

ABUS : 3.17 (-3.35%)

Business Summary

Arbutus Biopharma Corporation is a biopharmaceutical company which is focused on discovering, developing and commercializing a portfolio of drug candidates for chronic hepatitis B infection. The Company's products include TKM-HBV, Cyclophilin Inhibitor-OCB-030, TLR9 Agonist (CYT-003), Capsid Assembly...

See More

Key Turning Points

3rd Resistance Point 3.41
2nd Resistance Point 3.34
1st Resistance Point 3.25
Last Price 3.17
1st Support Level 3.09
2nd Support Level 3.02
3rd Support Level 2.93

See More

52-Week High 4.72
Fibonacci 61.8% 3.95
Fibonacci 50% 3.71
Fibonacci 38.2% 3.47
Last Price 3.17
52-Week Low 2.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar